Skip to content

role of Homoeopathic medicines in cases of Down Syndrome

Usefulness of Individualized Homoeopathic Medicines in Children with Down’s Syndrome: An Exploratory Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065355
Enrollment
30
Registered
2024-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q90- Down syndrome

Interventions

Intervention1: Homoeopathic medicine: 15 months study 6 months enrolment 6 months follow up 3 months data analysis Oral route of administration Pill form 30 Pill size Centesimal scale First dose after

Sponsors

Prinicpal Bakson Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children above 6 years of age and below 15 years of age Both male and female Children diagnosed with Down s Syndrome

Exclusion criteria

Exclusion criteria: Dependence on any kind of substances Participant suffering from uncontrolled systemic illness or life threatening any vital organ or any malignancy

Design outcomes

Primary

MeasureTime frame
It is expected to have positive change on TACQOL PF ScaleTimepoint: 15 months study 6 months enrolemnt 6 months follow up 3 months data analysis TACQOL PF Scale to be used at Baseline then 12 weeks and then 24 weeks

Secondary

MeasureTime frame
Not ApplicableTimepoint: NIL

Countries

India

Contacts

Public ContactDr Ritu Gontiya

Bakson Homoeopathic Medical College and Hospital

ojasvisingla98@gmail.com9354637294

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026